Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATESS: Vitamin C and Thiamine for Septic Shock
NCT03756220Phase 2Completed
- Start
- Dec 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in septic shock comparing Vitamin C + Thiamine with Placebo (2 arms). Primary endpoint: Delta Sequential Organ Failure Assessment Score at 72 hours. Started Dec 2018; status: completed.
02
Drugs
ascorbic acidthiamine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03756220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03756220.